Item 2.02. Results of Operations and Financial Condition.

On August 13, 2021, Chemomab Therapeutics Ltd. (the "Company") issued a press release announcing its financial results for its second quarter ended June 30, 2021. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

The information contained herein and in the accompanying exhibit are "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit
Number      Exhibit Description
  99.1        Press release issued by Chemomab Therapeutics Ltd. dated
            August 13, 2021.



                                        2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses